Dr. Matthew McMahon completed his graduate studies in retinal structure, function, and visual perception at the University of California, San Diego and performed postdoctoral research in primate retinal physiology at the University of Washington. He then served as Senior Principal Scientist for Second Sight Medical Products for 5 years. In 2009, Dr. McMahon moved to Capitol Hill as a AAAS Science and Technology Policy Fellow for the Senate Committee on Commerce, Science, and Transportation. He then served as professional staff on the House Science and Technology Committee, where he oversaw innovation, manufacturing, technology transfer, and bioscience policy. In his role at the National Eye Institute, Dr. McMahon facilitates existing translational research activities and participates in inter-agency initiatives. He is also responsible for identifying emerging opportunities to advance small molecules, gene- and cell-based therapies, medical devices, and other novel therapeutics through public-private partnering with the pharmaceutical and biotechnology industries.